Nikkei Xtech (July 25, 2022) published an article on why Kaken Pharmaceutical adopted Elix Discovery™
The July 25, 2022 issue of Nikkei Xtech published the following article.
“Why Kaken Pharmaceutical, a mid-sized pharmaceutical company, adopted Elix Discovery, a new integrated tool for AI drug discovery by startup Elix?”
There are comments by Kaken Pharmaceutical on the benefits of Elix Discovery™ from the perspective of a pharmaceutical company.
Please refer to the following news releases of Elix and Kaken for more details.
News release of Kaken
Kaken introduced “Elix Discovery™“, an AI Drug Discovery Platform